包容性临床试验的障碍与策略:焦点小组对包容性、多样性、公平性和可及性的见解
该研究通过两个面对面焦点小组,纳入20名研究者、医疗提供者、患者伙伴、原住民代表等利益相关者,探讨加拿大临床试验中公平参与的障碍、促进因素与策略,并为开发IDEA工具包收集意见。参与者识别出信任缺乏、试验知识有限、语言沟通挑战、物流监管障碍及研究负担与把关等五类障碍。
要点
- 关键障碍包括信任缺乏、试验知识有限、语言沟通挑战、物流监管障碍及研究负担与把关。
- 促进因素包括社区参与、文化相关代表性外展、多语言可及材料、灵活试验实施及招募留存支持。
- 利益相关者提出了加拿大IDEA工具包的实用模块化优先事项。
核心结论
- 该探索性研究识别了塑造包容性试验参与的结构性、关系性和操作性因素,并为IDEA工具包提供了基于情境的优先事项。
研究设计与样本
- 在加拿大开展两个面对面定性焦点小组,共纳入20名利益相关者,包括研究者、医疗提供者、患者伙伴、原住民代表及其他具有临床试验参与相关生活或专业经验者。
- 录音转录后使用NVivo 15采用归纳主题分析法进行分析。
主要发现
- 参与者识别出五类包容性参与障碍:信任缺乏;临床试验知识与健康研究素养有限;语言与沟通挑战;物流与监管挑战;研究负担与把关。
- 促进因素包括社区参与、文化相关代表性与外展、多语言与可及材料、灵活可及的试验实施、招募与留存支持。
- 利益相关者还确定了实用、模块化加拿大IDEA工具包的优先事项。
临床怎么用
- 研究结果为开发面向研究者的IDEA工具包提供了基于情境的优先事项,可适应不同试验环境。
局限性
- 该研究为探索性定性研究,发现不代表所有服务不足社区,但提供了可跨试验环境调整的实践教训。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical trials are essential for advancing healthcare, yet they often underrepresent key populations, which can limit the applicability of findings to populations for whom interventions are intended and perpetuate inequities in the evidence base. In Canada, practical, context-specific resources to support inclusive trial design and conduct remain limited. OBJECTIVE: To explore barriers, facilitators, and strategies related to equitable participation in Canadian clinical trials and to gather stakeholder input to inform development of an Inclusion, Diversity, Equity, and Accessibility (IDEA) toolkit for researchers. METHODS: We conducted two in-person qualitative focus groups with 20 stakeholders, including researchers, healthcare providers, patient partners, Indigenous representatives, and other participants with lived or professional experience relevant to clinical-trial participation. Audio recordings were transcribed and analyzed in NVivo 15 using an inductive thematic-analysis approach. RESULTS: Participants identified five barriers to inclusive participation: lack of trust; limited clinical-trial knowledge and health research literacy; language and communication challenges; logistical and regulatory challenges; and study burden and gatekeeping. Facilitators included community engagement, culturally relevant representation and outreach, multilingual and accessible materials, flexible and accessible trial delivery, and recruitment and retention supports. Stakeholders also identified priorities for a practical, modular Canadian IDEA toolkit. CONCLUSION: This exploratory study identifies structural, relational, and operational factors that shape inclusive trial participation and provides context-informed priorities for an IDEA toolkit. The findings are not intended to represent all underserved communities, but they offer practical lessons that can be adapted across trial settings.
引用
- Buragadda S, Friedman E, Clavel MA, et al. Barriers and Strategies for Inclusive Clinical Trials: Focus Group Insights on Inclusivity, Diversity, Equity, and Accessibility. J Clin Epidemiol. 2026. PMID: 42855087. doi:10.1016/j.jclinepi.2026.112551
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。